Skip to content

Jiangsu Hengrui Medicine Co Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 27, 2026 results vs estimates

Jiangsu Hengrui Medicine Co Ltd · E.600276.SHG · China
Use symbol E.600276.SHG in our API & Excel add-in to retrieve this data ↓
49.31
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend -25%
Bubble Risk LOW
Realised Volatility (20D) 35.04%

Jiangsu Hengrui Medicine Co Ltd Forecast

Jiangsu Hengrui Medicine Co Ltd short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is negative (3 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 35.0% a year, a typical one-standard-deviation range is 46.88–51.74 over a week, 44.32–54.30 over a month and 32.03–66.59 over a year. (Signals as of 5 Nov 2026.)

Jiangsu Hengrui Medicine Co Ltd Price Chart

MacroFinance.ai

Jiangsu Hengrui Medicine Co Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Jiangsu Hengrui Medicine Co Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Jiangsu Hengrui Medicine Co Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Jiangsu Hengrui Medicine Co Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Jiangsu Hengrui Medicine Co Ltd
P/E
36.84x
Cheap vs own history
QoQ −10.2%
YoY −30.0%
now 36.842235.12 low55.96 high
ⓘP/E As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
P/S
9.96x
Cheap vs own history
QoQ −1.5%
YoY −21.4%
now 9.96289.04 low13.49 high
ⓘP/S As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
P/B
4.90x
Cheap vs own history
QoQ −0.3%
YoY −25.8%
now 4.89834.39 low7.02 high
ⓘP/B As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Earnings Yield
2.7%
Strong vs own history
QoQ +11.3%
YoY +42.8%
now 2.71431.79 low2.85 high
ⓘEarnings Yield As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Market Cap
$327.3B
Mid-range vs own history
QoQ +3.3%
YoY −16.7%
now 327280.3258283,209 low424,282 high
ⓘMarket Cap As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Jiangsu Hengrui Medicine Co Ltd
Current Ratio
7.91x
Weak vs own history
QoQ −32.3%
YoY +20.8%
now 7.90966.55 low11.68 high
ⓘCurrent Ratio As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Quick Ratio
7.47x
Mid-range vs own history
QoQ −32.0%
YoY +20.5%
now 7.46856.2 low10.98 high
ⓘQuick Ratio As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Interest Coverage
1642.20x
Strong vs own history
QoQ +22.0%
YoY +179.1%
now 1642.2003588.39 low2,337 high
ⓘInterest Coverage As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Piotroski F-Score
3
Mid-range vs own history
QoQ +200.0%
YoY 0.0%
now 31 low3 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Jiangsu Hengrui Medicine Co Ltd
Altman Z-Score
23.36
Weak vs own history
QoQ −33.8%
YoY −24.3%
now 23.362222.38 low38.66 high
ⓘAltman Z-Score As of 22 Nov 2026.See Jiangsu Hengrui Medicine Co Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  14 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  11 members-only factors: Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index, Sales Growth Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Jiangsu Hengrui Medicine Co Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Jiangsu Hengrui Medicine Co Ltd fundamentals: income statement, balance sheet & cash flow

Jiangsu Hengrui Medicine Co Ltd reported revenue of 31.43bn CNY and net income of 7.71bn CNY in FY2025, the year ended 31 December 2025 — revenue up 12.3% and net income up 21.7% on the prior year. Free cash flow was 8.32bn CNY. These figures are as reported in the filings, not restated: 29 fiscal years and 99 quarters of history, back to December 1997.

Revenue (FY2025)
31.43bn CNY
+12.3%
Net income
7.71bn CNY
+21.7%
Gross margin
84.87%
Free cash flow
8.32bn CNY
+52.7%
Net debt
-40.02bn CNY
Jiangsu Hengrui Medicine Co Ltd income statement, annual, as reported · CNY billions unless stated
CNY billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue31.4327.9822.8221.2825.91
Cost of revenue4.763.883.563.503.76
Gross profit26.6724.1019.2617.7722.15
Research & development6.676.584.954.895.94
Selling, general & admin.—10.039.398.7711.54
Operating income8.027.494.914.114.66
EBITDA8.967.194.843.604.26
Interest expense0.020.010.010.010.00
Pre-tax income8.717.174.673.974.47
Income tax0.990.830.390.15-0.02
Net income7.716.344.303.914.53

Download Jiangsu Hengrui Medicine Co Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.600276.SHG&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 29 fiscal years and 99 quarters, the filing vintages behind each number and API access.
Create free account

Figures in CNY, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Jiangsu Hengrui Medicine Co Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Jiangsu Hengrui Medicine Co Ltd Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Jiangsu Hengrui Medicine Co Ltd; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Jiangsu Hengrui Medicine Co Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Jiangsu Hengrui Medicine Co Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Jiangsu Hengrui Medicine Co Ltd (China)

Jiangsu Hengrui Medicine Co Ltd is a listed security in China. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Jiangsu Hengrui Medicine Co Ltd?
Jiangsu Hengrui Medicine Co Ltd is a listed security in China. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Jiangsu Hengrui Medicine Co Ltd price?
The latest close is 49.31 (5 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Jiangsu Hengrui Medicine Co Ltd in an uptrend?
As of 5 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is negative (3 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Jiangsu Hengrui Medicine Co Ltd?
20-day realised volatility is 35.0% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 10.1% over a month and 4.9% over a week.
What factors affect Jiangsu Hengrui Medicine Co Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Jiangsu Hengrui Medicine Co Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Jiangsu Hengrui Medicine Co Ltd?
28 backtested tactical asset allocation strategies trade Jiangsu Hengrui Medicine Co Ltd through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Jiangsu Hengrui Medicine Co Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Jiangsu Hengrui Medicine Co Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Jiangsu Hengrui Medicine Co Ltd historical data?
In the Free historical data section of this page: the last 10 years of Jiangsu Hengrui Medicine Co Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Jiangsu Hengrui Medicine Co Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Jiangsu Hengrui Medicine Co Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.600276.SHG&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2047
2026-11-1946.88
2026-11-1846.9
2026-11-1747.66
2026-11-1648.02
2026-11-1348.07
2026-11-1247.93
2026-11-1148.22
2026-11-1048.55
2026-11-0949.23
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.